Uzm. Dr. Hüseyin Sancar Bozkurt

Uzm. Dr. Hüseyin Sancar Bozkurt

Gastroenteroloji

Kişisel Bilgiler

figure

Acil Durumlar

0216 585 32 00

Uzm. Dr. Hüseyin Sancar Bozkurt

Eğitimi:

Yıl Derece Okul
2003 Trakya Üniversitesi Tıp Fakültesi
2009 İç Hastalıkları Uzmanlığı Çukurova Üniversitesi Tıp Fakültesi
2021 Gastroenteroloji Adana Başkent Üniversitesi
Doktor Öğretim Üyesi İstanbul Maltepe Üniversitesi Gastroenteroloji Kliniği

Deneyimi:

Yıl Bölüm Pozisyon Kurum
2009 Elâzığ Kovancılar Devlet Hastanesi
2009 - 2012 Başkent Üniversitesi Adana Uygulama ve Araştırma Merkezi
2012 - 2014 Kahramanmaraş Necip Fazıl Şehir Hastanesi
2014 - 2015 Özel Defne Hastanesi
2015-2025 Özel Tarsus Medical Park Hastanesi
2025-Halen Özel Pendik Bölge Hastanesi

TIBBİ İLGİ ALANLARI

  • Endoskopi
  • Kolonoskopi
  • Disbiyosiz (Bağırsak Flora Bozukluğu)
  • İltihaplı Bağırsak Hastalıkları (Ülseratif Kolit, Crohn,Çölyak)
  • İBS
  • SİBO
  • Geçirgen Bağırsak
  • Bağırsak İlişkili Otoimmün rahatsızlıklar (Hashimato, DM, Alerji, Ürtiker, Egzama, Astım, Pankreas rahatsızlıkları)
  • Fonksiyonel İshal
  • Fonksiyonel Kabızlık
  • Bağırsak Divertikülleri
  • Probiyotikler

    • YAYINLAR

  • Hazan S, Stollman N, Bozkurt HS, et al Lost microbes of COVID-19: Bifidobacterium, Faecalibacterium depletion and decreased microbiome diversity associated with SARS-CoV-2 infection severity BMJ Open Gastroenterology 2022;9:e000871. doi: 10.1136/bmjgast-2022-000871
  • Hüseyin Sancar Bozkurt, Hülya Civelek Yörüklü; Kutsal Bozkurt; Cenk Denktaş; Altan Bozdoğan; Orhan Özdemir;Bestami Özkaya; Biodegradation of microplastic by probiotic bifidobacterium International Journal of Global Warming (IJGW), Vol. 26, No. 4, 2022
  • Denktaş, C., Baysoy, D. Y., Bozdoğan, A., Bozkurt, H. S., Bozkurt, K., Özdemir, O., & Yilmaz, M. (2022). Development and characterization of sodium alginate/bifidobacterium probiotic biohybrid material used in tissue engineering. Journal of Applied Polymer Science, 139(18), 52086. https://doi.org/10.1002/app.52086
  • Bozkurt, H. S., Bilen, Ö. (2021). Oral booster probiotic bifidobacteria in SARS-COV-2 patients. International Journal of Immunopathology and Pharmacology. https://doi.org/10.1177_20587384211059677
  • Bozkurt, H. S.,Bilen, Ö. (2021). Gastrointestinal symptoms in COVID-19 could be associated with severe lung involvement and increased readmission rates. European Journal of Inflammation. https://doi.org/10.1177_20587392211048259
  • Bozkurt HS, Quigley EM. The probiotic Bifidobacterium in the management of Coronavirus: A theoretical basis. International Journal of Immunopathology and Pharmacology. January 2020. doi:10.1177/2058738420961304
  • Bozkurt HS, Kara B. A new treatment for ulcerative colitis: Intracolonic Bifidobacterium and xyloglucan application. European Journal of Inflammation. January 2020. doi:10.1177/2058739220942626
  • Bozkurt, C. Denktas, O. Ozdemir, A. Altındal, Z. Avdan, H. S. Bozkurt. Charge Transport in Bifidobacterium animalis subsp.lactis BB-12 under Various Atmospheres.OJAPPS 2019. DOI: 10.4236/ojapps.2019.96040.
  • Hüseyin Sancar Bozkurt,Eamonn M. M. Quigley.Bifidobacteria and Mucosal-Associated Invariant T (MAIT) Cells: A New Approach to Colorectal Cancer Prevention?. Gastrointest. Disord. 2019, 1(2), 266-272; https://doi.org/10.3390/gidisord1020022
  • Hüseyin Sancar Bozkurt,Banu Kara.Combination of oral vancomycin and intra-colonic vancomycin: Successful treatment of complicated pseudomembranous colitis in a child patient.SAGE 2019;7: doi: 10.1177/2050313X19838442
  • Bozkurt, H.S., E. MM Quigley, B. Kara, 2019. Bifidobacterium animalis subspecies lactis engineered to produce mycosporin-like amino acids in colorectal cancer prevention. SOM 2019; Vol. 7: 1–5
  • Hüseyin Sancar Bozkurt,Banu Kara. Can Fortified Bifidobacterium with Mycosporin-like Amino Acid be a New Insight for Neurological Diseases’ Treatment?. Autism-Open Access 2017, 7:5.DOI: 10.4172/2165-7890.1000219
  • Bozkurt HS, Kara B. Bifidobacterium and Mycosporin-like Amino Acid Cooperation: A New Era for Intestinal Diseases Treatment?. J Gastric Disord Ther (2017) 3(2)

    • ÖDÜLLER

    1. Amerikan Gastroenteroloji Derneği “Klinisyenlere Tavsiye Ödülü 2017” https://www.mdedge.com/gihepnews/article/157083/register-early-aga-postgraduate-course)
    2. Amerikan Gastroenteroloji Derneği “2017 En Çok Katkıda Bulunan Başarısı” https://www.mdedge.com/gihepnews/article/157088/endoscopy/2017-gi-thought-leaders)
    3. Avrupa Gastroenteroloji Derneği Temel Bilimler Ödülü (2018) Bifidobacterium Animalis Subspecies Lactis Engineered To Produce Mycosporin- Like Amino Acids In Colorectal Cancer Prevention. UEG Week 2018 October 20-24, 2018, Vienna – Austria
    4. “Anneden Çocuğa Mikrobiyom” Symposia Amerika Burs Ödülü , Harnessing the Microbiome for Disease Prevention and Therapy  joint with MEETING CHANGE TO VIRTUAL: The Microbiome: From  Mother to Child Organizer(s): Eric G. Pamer, Laurie E. Comstock and Alan Walker Date: January 17 – 21, 2021, Scholarship award.
    5. COVİD19’da “Tek tür probiyotik bakteri tedavisi” , En iyi çalışma ve en iyi sunum ödülü, Kore Gastroenteroloji Haftası, KGFID award in KDDW2021
    6. Sigma Bilimsel Topluluk tam üyelik ödülü. Full Member of Sigma Xi, The Scientific Research Honor Society , 2024
    7. Amerikan Gastroenteroloji Uzmanlık ödülü, AGA Fellow, 2025